Dr. Salhia is an Associate Professor in the Department of Translational Genomics at the Keck School of Medicine, University of Southern California and a member of the Norris Comprehensive Cancer Center. She also serves as the Course Director for the Department of Radiation Oncology and has a cross appointment in the Department of Biochemistry and Molecular Medicine and is a member of the Keck School of Medicine Faculty Council. Dr. Salhia is a translational genomics scientist with extensive knowledge and expertise in mechanisms that underlie tumorigenesis and tumor biology. She merges cutting edge genomics/epigenomics analyses with cell biological and functional studies towards the investigation of clinically relevant problems in human cancer. Her main projects include 1) developing diagnostic and prognostic biomarkers using cell-free DNA methylation technology she has developed in her lab; 2) developing novel therapies for patients with brain metastasis using patient-derived xenografts developed in her lab and 3) understanding neuroepigenetic-mediated responses to transcorneal electrical stimulation for the potential treatment of retinal degeneration. Dr. Salhia is federally funded, well published and has led numerous projects and teams. Dr. Salhia earned her Bachelor of Science (B.Sc.), Master of Health Science (MHSc) and doctorate degree (PhD) at the University of Toronto. She completed her graduate training in molecular and cellular neuro-oncology at the Arthur and Sonia Labatt Brain Tumor Research Center at the Hospital for Sickkids in Toronto, Canada. She went on to complete a post-doctoral fellowship in cancer epigenomics at the Translational Genomics Research Institute in Phoenix, Arizona.
Finally, Dr. Salhia finds it extremely important to connect with the people her research is attempting to serve. She has given numerous community lectures and is avid volunteer. She has volunteered with the Arizona Myeloma Network, The Wellness Community, and Susan G. Komen affiliate in Phoenix. She has travelled to Egypt as a US Delegate with the Susan G. Komen for the Cure to raise awareness about breast cancer and she has worked with underserved minorities on the Navajo Nation in Arizona. She served as a Community Outreach Ambassador and was a member of the Board of Directors for the Susan G. Komen for the Cure Arizona between 2012-2016. She has received numerous community awards including a service award by the Arizona Myeloma Network. She was also named one of 20 Faces of Komen in 2012 and 2013 and in June 2014 was the recipient of the Phoenix Business Journal’s Top 40 under 40 award.